This immunochemical fecal occult blood test features high specificity and sensitivity, and is clinically proven to detect bleeding associated with more cancers and polyps than traditional guaiac-based tests.
- High specificity
- Clinically proven
The superior specificity for lower gastrointestinal bleeding enables it to be an ideal screening tool for colorectal cancer and reduces the number of false positive test results. Test is safe, non-invasive, and has no diet or drug restrictions for patients to follow while they are using it, helping to increase patient compliance.
Certifications: Test is CLIA waived.
Ordering information: Patient screening kits 89013-348 are supplied with 40 patient screening kits and physician instructions. Each patient screening kit contains one dispensing envelope with patient instructions, three Hemoccult® ICT collection cards, three flushable collection tissues, three applicator sticks, and one mailing pouch. Collection cards 89013-346 are supplied with 100 cards, 100 applicator sticks, physician instructions, and sample collection instructions. Tests 89013-350 are supplied with 20 test devices, one 8mL bottle of Hemoccult® ICT Buffer, and product instructions. Tests are to be used with the collection cards and patient screening kits. Controls 89013-352 are supplied with four 0.8mL bottles (two positive and two negative) and control product instructions.